Anacor Pharmaceuticals, Inc.
(NASDAQ : ANAC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
2.33%43.120.9%$1175.90m
LLYEli Lilly and Company
1.48%124.531.0%$1057.71m
JNJJohnson & Johnson
0.75%136.430.6%$990.66m
MRKMerck & Co., Inc.
1.10%80.710.6%$958.81m
BMYBristol-Myers Squibb Company
1.32%50.791.4%$779.20m
ABBVAbbVie, Inc.
1.37%79.832.2%$665.50m
AZNAstraZeneca PLC Sponsored ADR
0.88%40.791.3%$194.88m
NVSNovartis AG Sponsored ADR
0.35%90.830.2%$187.56m
GSKGlaxoSmithKline plc Sponsored ADR
-0.05%40.520.2%$136.51m
NVONovo Nordisk A/S Sponsored ADR Class B
0.14%49.730.1%$70.32m
SNYSanofi Sponsored ADR
-0.29%41.210.2%$36.75m
LCILannett Company, Inc.
1.87%9.5336.7%$16.74m
AKTXAkari Therapeutics Plc Sponsored ADR
0.00%1.851.7%$0.06m
EPIXESSA Pharma Inc
5.57%3.770.1%$0.05m

Company Profile

Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA.